Advertisement

Topics

Search Results for "Xarelto Vs Pradaxa"

01:49 EST 3rd December 2016 | BioPortfolio

Matching Channels

Rivaroxaban

Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...

Matching News

Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa

MONDAY, Oct. 3, 2016 -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research s...

Venous Thromboembolism therapeutics market set to hit $3.7 bn by 2025

Biospectrum Pradaxa, Xarelto, and Eliquis, which are all currently available, will see improved uptake over the forecas...

Portola's anticoagulant antidote gets EU review

Portola has said European regulators are to review its anticoagulantĀ antidote, IndexXa (andexanet alfa), just days after the US regulator rejected the drug. California-based Portola said the Europea...

BRIEF-Bayer comments on the article in "Handelsblatt" on Xarelto

* Believes statements published in 'Handelsblatt' on Nov. 9. about Xarelto are misleading

Janssen: Less Bleeding with Xarelto in Some Patients

NewsPhase 3b study shows significantly less bleeding with Xarelto (rivaroxaban) compared to Warfarin in people with non-valvular atrial fibrillation following percutaneous coronary intervention with s...

FDA clears Xarelto blood thinner despite faulty trial device

The U.S. Food and Drug Administration on Tuesday said it has determined the widely-used blood thinner Xarelto to be safe and effective for patients with the heart condition atrial fibrillation after s...

U.S. FDA clears Xarelto blood thinner despite faulty trial device

Oct 11 (Reuters) - The U.S. Food and Drug Administration on Tuesday said it has determined the widely-used blood thinner Xarelto to be safe and effective for patients with the heart condition atrial f...

Xarelto Clinical Trial Likened To 'Science Fair Project' By Philly Malpractice Lawyer

The quality and depth of clinical trials of the blood-thinner Xarelto could be a key issue when the first trials over the drug begin in Philadelphia courtrooms. With the first trial of more than 800 l...

Matching PubMed Articles

Praxbind Available as Antidote to Bleeding from Pradaxa.

Caution When Prescribing Xarelto to First-Time Patients.

Effects of Rivaroxaban Therapy on ROTEM Coagulation Parameters in Patients with Venous Thromboembolism.

Rivaroxaban (Xarelto) does not require routine coagulation monitoring; however, in certain clinical situations (overdose, drug accumulation, urgent surgery) measurement of its plasma concentration is ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement